화학공학소재연구정보센터
Korean Journal of Materials Research, Vol.21, No.6, 347-351, June, 2011
의사체액에서 수산화아파타이트의 결정성에 따른 분해거동
Degradation Behavior of Hydroxyapatite with Different Crystallinity in Simulated Body Fluid Solution
E-mail:
Hydroxyapatite (HAp) powders with different crystallinities were synthesized at various calcination temperatures through the co-precipitation of Ca(OH)2 and H3PO4. The degradation behavior of these HAp powders with different crystallinities was assessed in a simulated body fluid solution (SBF) for 8 weeks. Below 800oC, the powders were nonstochiometric HAp, and the single HAp phase was successfully synthesized at 800oC. The degree of crystallinity of the HAp powders increased with an increasing calcination temperature and varied in a range from 39.6% to 92.5%. In the low crystallinity HAp powders, the Ca and P ion concentrations of the SBF solution increased with an increasing soaking time, which indicated that the low crystallinity HAp degraded in the SBF solution. The mass of the HAp powders linearly decreased with respect to the soaking time, and the mass loss was higher at lower crystallinities. The mass loss ranged from 0.8% to 13.2% after 8 weeks. The crystallinity of the HAp powders increased with an increasing soaking time up to 4 weeks and then decreased because of HAp degradation. The pH of the SBF solution did not change much throughout the course of these experiments. These results suggested that the crystallinity of HAp can be used to control the degradation.
  1. Groot KD, Biomaterials, 1, 47 (1980)
  2. De Bruijn JD, Bovell YP, Van Blittterswijk CA, Biomaterials, 15, 543 (1994)
  3. Nunes CR, Simske SJ, Sachdeva R, Wolford LM, J. Biomed. Mater. Res., 36, 560 (1997)
  4. Heise U, Osborn JF, Duwe F, Int. Orthop., 14, 329 (1990)
  5. Kozo O, Yamamuro T, Nakamura T, Kokubo T, Biomaterials, 11, 265 (1990)
  6. Song HY, Min YK, Yang HM, Mang JY, Korean J. Mater. Res., 17(12), 669 (2007)
  7. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR, Biomaterials, 27, 3413 (2006)
  8. Hench LL, J. Am. Ceram. Soc., 81, 1705 (1998)
  9. Hollinger JO, Battistone GC, Clin. Orthop. Relat. Res., 207, 290 (1986)
  10. Jin HH, Min SH, Hyun YT, Park HC, Yoon SY, Korean J. Mater. Res., 16(11), 676 (2006)
  11. Oonishi H, Kushitani S, Iwaki H, in Proceedings of the 8th International Symposium on Ceramics in Medicine (Ponte Vedra, FL, USA, Nov. 1995), ed. J. Wilson, L.L. Hench and D. Greenspan (Elsevier Science Ltd., USA, 1995) p.137. (1995)
  12. Oyane A, Nakanishi K, Kim HM, Miyaji F, Kokubo T, Soga N, Nakamura T, Biomaterials, 20, 79 (1999)
  13. Benedetti A, Cocco G, Fagherazzi G, Locardi B, Meriani S, J. Mater. Sci., 18, 1039 (1983)
  14. Kwon SH, Jun YK, Hong SH, Kim HE, J. Eur. Ceram. Soc., 23, 1039 (2003)
  15. Dorozhkin SV, Progr. Cryst. Growth Char. Mater., 44, 45 (2002)
  16. Kim HM, Miyazaki T, Kokubo T, Nakamura T, Key Engineering Materials, 192-195, 47 (2000)
  17. LeGeros RZ, Clin. Mater., 14, 65 (1993)
  18. Benahmed M, Bouler JD, Heymann D, Gan O, Daculsi G, Biomaterials, 17, 2173 (1996)